StockDriftsStockDriftsTop 3 Trv Gp V LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| RAPP | RAPPORT THERAPEUTICS, INC. | 52.53% | 6.28M | $261.7M | -11.98%(-854.71K) | $19.11(+151.99%) | 2026-06-30 | |
| SEPN | SEPTERNA, INC. | 41.78% | 6.22M | $208.2M | +0.00%(+0) | $22.90(+90.28%) | 2026-06-30 | |
| MAZE | MAZE THERAPEUTICS, INC. | 5.69% | 950.8K | $28.4M | +0.00%(+0) | $11.01(+143.82%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative | Since First Filing (6 quarters) |
|---|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — | +70.06% |
| Top 20 Holdings Unweighted | — | — | — | — | +30.89% |
Trv Gp V LLC reports $498.24M in US-listed equity holdings across 3 positions in its most recent 13F filing. Its largest disclosed positions are RAPP (52.5%), SEPN (41.8%) and MAZE (5.7%). The top 20 holdings account for 100% of reported assets. Its disclosed equity book has returned +70.06% cumulatively over 6 quarters. Figures reflect the Q2 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Trv Gp V LLC, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Trv Gp V LLC’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1990717). View Trv Gp V LLC’s 13F filings on SEC